February 16, 2017 — Cerveau Technologies Inc. announced it has signed an agreement with Siemens’ PETNET Solutions Inc ...
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of ...
February 6, 2017 — A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
January 30, 2017 — IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced ...
January 17, 2017 — NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of ...
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of ...
January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been ...
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on ...
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected ...
November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s ...
October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the ...
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 ...
October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 ...
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3 ...
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) ...
September 6, 2016 — Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with ...
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
February 16, 2017 